![]()
|
|
||||||||
J. Biol. Chem., Vol. 279, Issue 25, 26555-26562, June 18, 2004
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||



¶
||
From the
Section of Neurobiology, Physiology, and Behavior, University of California, Davis, California 95616-8519 and the **Departments of Pharmaceutical Chemistry and Cellular and Molecular Pharmacology, University of California, San Francisco, California 94143-0446
A major challenge in understanding nuclear hormone receptor function is to determine how the same ligand can cause very different tissue-specific responses. Tissue specificity may result from the presence of more than one receptor subtype arising from multiple receptor genes or alternative splicing. Recently, high affinity analogs of nuclear receptor ligands have been synthesized that show subtype selectivity. These analogs can greatly facilitate the study of receptor subtype-specific functions in organisms where mutational analysis is problematic or where it is desirable for receptors to be expressed in their normal physiological contexts. We describe here the effects of the synthetic thyroid hormone analog GC-1 on the metamorphosis of the frog Xenopus laevis. The most potent natural thyroid hormone, 3,5,3'-triidothyronine or T3, shows similar binding affinity and transactivation dose-response curves for both thyroid hormone receptor isotypes, designated TR
and TR
. GC-1, however, binds to and activates TR
at least an order of magnitude better than it does TR
. GC-1 efficiently induces death and resorption of premetamorphic tadpole tissues such as the gills and the tail, two tissues that strongly induce thyroid hormone receptor
during metamorphosis. GC-1 has less effect on the growth of adult tissues such as the hindlimbs, which express high TR
levels. The effectiveness of GC-1 in inducing tail resorption and tail gene expression correlates with increasing TR
levels. These results illustrate the utility of subtype selective ligands as probes of nuclear receptor function in vivo.
Received for publication, March 15, 2004
* This work was supported by National Institutes of Health Grants DK-52798 (to T. S. S.) and DK-55511 (to J. D. F.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
¶ Present address: Dept. of Biochemistry, Dartmouth College, Hanover, NH 03755.
|| Present address: St. Louis University School of Medicine, St. Louis, MO 63104.
To whom correspondence should be addressed: Section of Neurobiology, Physiology, and Behavior, University of California, 1 Shields Ave., Davis, CA 95616-8519. E-mail: jdfurlow{at}ucdavis.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
C. M Villicev, F. R S Freitas, M. S Aoki, C. Taffarel, T. S Scanlan, A. S Moriscot, M. O Ribeiro, A. C Bianco, and C. H A Gouveia Thyroid hormone receptor {beta}-specific agonist GC-1 increases energy expenditure and prevents fat-mass accumulation in rats J. Endocrinol., April 1, 2007; 193(1): 21 - 29. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Columbano, M. Pibiri, M. Deidda, C. Cossu, T. S. Scanlan, G. Chiellini, S. Muntoni, and G. M. Ledda-Columbano The Thyroid Hormone Receptor-{beta} Agonist GC-1 Induces Cell Proliferation in Rat Liver and Pancreas Endocrinology, July 1, 2006; 147(7): 3211 - 3218. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Opitz, S. Hartmann, T. Blank, T. Braunbeck, I. Lutz, and W. Kloas Evaluation of Histological and Molecular Endpoints for Enhanced Detection of Thyroid System Disruption in Xenopus laevis Tadpoles Toxicol. Sci., April 1, 2006; 90(2): 337 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Liu and G. A. Brent Thyroid Hormone-Dependent Gene Expression in Differentiated Embryonic Stem Cells and Embryonal Carcinoma Cells: Identification of Novel Thyroid Hormone Target Genes by Deoxyribonucleic Acid Microarray Analysis Endocrinology, February 1, 2005; 146(2): 776 - 783. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |